We craft a perfect roadmap to success!
The pharma industry has started realizing the potential of collaborating with technology and is presently dominated by some of the top spenders on pharmaceutical R&D from the U.S. This includes ace companies such as Pfizer, Merk, Bristol-Myers Squibb, Celgene corp, etc., each of them investing billions of dollars every quarter.
On similar lines, because of the availability of sophisticated technology and a well-developed infrastructure for R&D, Singapore has emerged as one of Asia’s most advanced hubs for pharmaceutical research and manufacturing.
With a combined market capitalization of approximately $1.9 trillion, the wave of technology has even influenced the big threes of the market, i.e. Apple, Google, and Amazon, to invest heavily in the pharma and health sector today.
Here are the ways technology is enabling the pharma industry to reduce its expenditure while continuing to sustain its longevity.
Although the end-users of pharmaceutical companies are the patients who consume their products, the pharma companies don’t usually get the opportunity to connect with them directly.
Technological advancements such as mobile apps have given pharma companies a way to engage with their customers individually.
Many pharmaceutical companies can now help patients directly with the availability of smartphones. Companies like Novartis have taken a similar initiative by introducing apps like Together in HF. This social network connects the heart patient community and the doctors to provide valuable medical content to the patients.
Technology has made it possible to deliver personalized diagnoses to patients today. With devices like wearables in healthcare, a repository of customer data has become accessible to pharma companies. With the help of smartphones, it has become possible to access this data in an organized fashion, thereby becoming an instrument for offering efficient diagnostics and bespoke patient care.
Companies like Proteus Digital Health have been able to explore the utility of technology to produce ingestible sensors to help physicians track and monitor patients on smartphones.
Technology in the pharmaceutical industry will also help end the ethical dilemmas of testing drugs on humans. Not only will this method save time and capital, but it will also be more reliable.
Another advantage of teaming technology with the pharmaceutical industry is the improvement in research and development. By bringing real-time technology and clinical trials together, pharma companies can establish a stronger foothold in R&D.
With high productivity, inventory, and service levels, the drug production process can reach its maximum potential in less time.
Pharmaceutical companies will be able to access accurate patient data, which will assist these companies in understanding the after-effects of a drug.
With constant monitoring of symptoms and signals, drug development companies can understand their products better and provide relevant reporting to the FDA (Food and Drug Administration).
Motivation works better than commands. Using mobile apps for gamifying procedures, medical advice, and products for physicians and patients will increase their adherence and prompt them to follow a healthier lifestyle.
Replacing the traditional advertising and incentivization techniques with gamifying experiences will enable the customers to absorb the information about their options better and be better engaged.
Many reputed pharmaceutical companies have already started exploiting technology to grow their business. For example, Pharma giant Sun Pharma launched a revolutionary mobile app for asthma patients called RespiTrack in 2016.
The app helps doctors to monitor patients’ progress and increase their medication compliance. Similarly, Abbott Healthcare introduced a heart and liver app called Knowledge Genie that helps physicians to access patients’ medical information quickly.
Such innovations in apps from the pharma industry can inspire the creation of similar apps for monitoring patients’ health.
With the IoT healthcare market reaching an estimated 136 billion USD by 2021, companies from the pharmaceutical sector are collaborating with tech companies to create devices that can track and monitor various chronic and lifestyle disorders using real-time data.
Presently 3D Bioprinting or additive manufacturing is one of the leading innovations in the medicine production industry. It is still very novel in the pharmaceutical sector, with the very first 3D-printed prescription drug, Spritam, being developed in 2016. 3D Bio-Printing can be widely used for printing drugs with different release rates, printing live tissues, and also for drug tablet printing with a personalized dosage.
Through AI and machine learning, it has become possible for pharma companies to interpret patient data to understand the physiological patterns of humans. Solutions driven by AI have been able to help pharma companies to even identify and predict results in a virtual patient.
With the rapidly changing world of technology, the medicine and healthcare industry is beginning to revolutionize. It’s time that pharma companies who aspire to become business leaders in the pharma world found new disruptive solutions to thrive and rise on the digital wave to save on colossal resources and time.
mTraction enterprise provides mobile application development solutions to promote operational mobility and overall decision-making. Learn more about how our digital transformation solutions are helping Pharmaceutical enterprises enhance their business processes. Drop us a note at email@example.com.
It was only a matter of time before the world of apps extended…Read More
In the past few years, the focus of businesses has shifted from profit…Read More
Mobile app market has been flourishing since Apple launched its first smartphone just…Read More
Apple and Samsung’s strength in the US smartphone market is continuing to grow…Read More
Times we live in are extremely exciting for any startup company. They are…Read More
Introduction The launch of Apple’s iPhone X in the revolutionary market of smartphones…Read More